Search Articles

View query in Help articles search

Search Results (1 to 3 of 3 Results)

Download search results: CSV END BibTex RIS


Using Deep Learning to Perform Automatic Quantitative Measurement of Masseter and Tongue Muscles in Persons With Dementia: Cross-Sectional Study

Using Deep Learning to Perform Automatic Quantitative Measurement of Masseter and Tongue Muscles in Persons With Dementia: Cross-Sectional Study

Moreover, head muscles such as the tongue and masseter could be cost-effective alternatives to estimate muscle mass in dementia and other common conditions such as head cancer, stroke, or cranioencephalic trauma [14,15]. However, manual and semi-automatic techniques are labor-intensive and time-consuming, making the image processing task for large studies difficult, expensive, and, most importantly, impractical to apply in a clinical setting.

Mahdi Imani, Miguel G Borda, Sara Vogrin, Erik Meijering, Dag Aarsland, Gustavo Duque

JMIR Aging 2025;8:e63686

Performance of GPT-4V in Answering the Japanese Otolaryngology Board Certification Examination Questions: Evaluation Study

Performance of GPT-4V in Answering the Japanese Otolaryngology Board Certification Examination Questions: Evaluation Study

Questions were categorized into fields, such as ear; nasal allergy; speech, swallowing, and larynx; oropharynx; head and neck; general; and infectious disease. Question content was classified as treatment, details of the disease and diagnosis, examination, anatomy, systems, and others.

Masao Noda, Takayoshi Ueno, Ryota Koshu, Yuji Takaso, Mari Dias Shimada, Chizu Saito, Hisashi Sugimoto, Hiroaki Fushiki, Makoto Ito, Akihiro Nomura, Tomokazu Yoshizaki

JMIR Med Educ 2024;10:e57054

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial

Head and neck cancers (HNCs) are among the most common malignancies worldwide, affecting more than 740,000 patients and resulting in 360,000 deaths per year [1]. Treatment for nonmetastatic HNC depends on disease stage and localization and usually requires multimodal approaches comprising surgery, radiotherapy, and concomitant systemic treatments [2-4].

Tanja Sprave, Michelle Pfaffenlehner, Raluca Stoian, Eleni Christofi, Alexander Rühle, Daniela Zöller, Alexander Fabian, Harald Fahrner, Harald Binder, Henning Schäfer, Eleni Gkika, Anca-Ligia Grosu, Felix Heinemann, Nils Henrik Nicolay

J Med Internet Res 2023;25:e46189